2-Benzyloxycarbonylamino-3-{2-[(S)-4-(2-guanidino-ethyl)-2,5-dioxo-imidazolidin-1-yl]-acetylamino}-propionic acid anion

ID: ALA1160222

PubChem CID: 44296742

Max Phase: Preclinical

Molecular Formula: C19H25N7O7

Molecular Weight: 463.45

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)NCC[C@@H]1NC(=O)N(CC(=O)NCC(NC(=O)OCc2ccccc2)C(=O)O)C1=O

Standard InChI:  InChI=1S/C19H25N7O7/c20-17(21)22-7-6-12-15(28)26(18(31)24-12)9-14(27)23-8-13(16(29)30)25-19(32)33-10-11-4-2-1-3-5-11/h1-5,12-13H,6-10H2,(H,23,27)(H,24,31)(H,25,32)(H,29,30)(H4,20,21,22)/t12-,13?/m0/s1

Standard InChI Key:  MIKCNEPEXKKSOM-UEWDXFNNSA-N

Molfile:  

     RDKit          2D

 33 34  0  0  0  0  0  0  0  0999 V2000
    4.0417   -0.7792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.7875   -1.5667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3750   -0.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9625   -1.5667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7125   -0.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6250   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0250   -1.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7917   -0.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2375   -1.6750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8292   -0.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1875   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4375   -1.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2750   -2.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1875   -2.0625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3750    0.5250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2250   -0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8375   -1.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5750   -0.0542    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1917   -0.6042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.1750    0.2375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6375   -1.9625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.2667   -1.8875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5250   -0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9083   -0.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9250   -0.5250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4250   -1.7042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3125   -1.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0375   -2.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8625   -3.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8125   -2.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4250   -2.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4750   -3.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2625   -3.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6 17  1  0
  7  9  1  0
  8  6  1  0
  9  6  1  0
 10  1  1  0
 11 23  1  0
 12 10  1  0
 13  2  2  0
 14 11  2  0
 15  3  2  0
 16 12  1  0
 17 16  1  0
 18  8  1  0
 19  7  2  0
 20  8  2  0
 21  7  1  0
 22 12  2  0
 23 27  1  0
 24 11  1  0
  5 25  1  1
 26 21  1  0
 27 25  1  0
 28 26  1  0
 29 28  2  0
 30 28  1  0
 31 30  2  0
 32 29  1  0
 33 31  1  0
  5  4  1  0
 32 33  2  0
M  END

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-IIb/beta-3 (3481 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ITGB3 Tclin Integrin alpha-V/beta-3 (2708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 463.45Molecular Weight (Monoisotopic): 463.1815AlogP: -1.72#Rotatable Bonds: 11
Polar Surface Area: 216.04Molecular Species: ZWITTERIONHBA: 7HBD: 7
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.42CX Basic pKa: 12.17CX LogP: -3.78CX LogD: -3.78
Aromatic Rings: 1Heavy Atoms: 33QED Weighted: 0.11Np Likeness Score: -0.58

References

1. Peyman A, Wehner V, Knolle J, Stilz HU, Breipohl G, Scheunemann KH, Carniato D, Ruxer JM, Gourvest JF, Gadek TR, Bodary S..  (2000)  RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirements.,  10  (2): [PMID:10673106] [10.1016/s0960-894x(99)00661-7]

Source